Patent application number | Description | Published |
20080230843 | Isolation Structure for MOS Transistor and Method for Forming the Same - A method for forming isolation structure for MOS transistor is disclosed, which includes forming a first photoresist layer over a sacrificed oxide layer of a semiconductor substrate, patterning the first photoresist layer to define a PMOS active region and a PMOS isolation region; implanting nitrogen ions into the PMOS isolation region through the sacrificed oxide layer by using the first photoresist layer as a mask; removing the first photoresist layer; forming a second photoresist layer over the sacrificed oxide layer, patterning the second photoresist layer to define a NMOS active region and a NMOS isolation region; implanting oxygen ions into the NMOS isolation region through the sacrificed oxide layer by using the second photoresist layer as a mask; removing the second photoresist layer and the sacrificed oxide layer; and annealing the semiconductor substrate to form isolation structures of PMOS and NMOS, respectively. | 09-25-2008 |
20080275055 | IMATINIB PRODUCTION PROCESS - Provided is a process for producing imatinib and salts thereof, e.g., imatinib mesylate. The process includes reacting4-(4-methyl-piperazin-1-ylmethyl)-benzoic acid with N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine in the presence of a carboxylic acid coupling reagent, to produce imatinib, and optionally converting the imatinib into a salt. | 11-06-2008 |
20090238843 | RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS - The invention relates to recombinant MVA which is capable of expressing structural HCV antigens, functional parts of said structural antigens or epitopes of said structural antigens. The invention further relates to a pharmaceutical composition, especially in the form of a vaccine and containing the recombinant MVA according to the invention, to eukaryotic cells that contain the inventive recombinant MVA and to various uses of the recombinant MVA, for example for producing recombinant structural proteins, for producing a pharmaceutical preparation that is suitable for the therapy and prophylaxis of HCV infections and diseases thereby caused. The invention further relates to methods for producing recombinant MVA and recombinant structural HCV polypeptides encoded by said recombinant MVA, and to DNA or RNA of said recombinant MVA. | 09-24-2009 |
20090273881 | Metal-Insulator-Metal Capacitor - The present invention provides a metal-insulator-metal capacitor, which comprises a semiconductor substrate; an interlayer dielectric layer disposed on the semiconductor substrate; and an insulation trench and two metal trenches all running through the interlayer dielectric layer and allowing the semiconductor substrate to be exposed; wherein the metal trenches being located on each side of the insulation trench and sharing a trench wall with the insulation trench respectively, the insulation trench being filled with insulation material as an insulation structure, the metal trenches being filled with metal material as electrodes of the capacitor. | 11-05-2009 |
20100174080 | NOVEL PALONOSETRON SALTS AND PROCESSES FOR PREPARATION AND PURIFICATION THEREOF - Provided are novel salts of 2-(1-azabicyclo-[2.2.2]oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one, methods of using such salts, and processes for producing such salts | 07-08-2010 |
20110060938 | COMPUTER INTERLOCKING SYSTEM AND CODE BIT LEVEL REDUNDANCY METHOD THEREFOR - A code bit level redundancy method for a computer interlocking system is provided. The method includes: (1) controlling the output in parallel, and (2) sharing the collected information. | 03-10-2011 |
20110293656 | RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS - The invention relates to recombinant MVA which is capable of expressing structural HCV antigens, functional parts of said structural antigens or epitopes of said structural antigens. The invention further relates to a pharmaceutical composition, especially in the form of a vaccine and containing the recombinant MVA according to the invention, to eukaryotic cells that contain the inventive recombinant MVA and to various uses of the recombinant MVA, for example for producing recombinant structural proteins, for producing a pharmaceutical preparation that is suitable for the therapy and prophylaxis of HCV infections and diseases thereby caused. The invention further relates to methods for producing recombinant MVA and recombinant structural HCV polypeptides encoded by said recombinant MVA, and to DNA or RNA of said recombinant MVA. | 12-01-2011 |
20130024469 | APPARATUS AND METHOD FOR PREVENTING REGRESSION DEFECTS WHEN UPDATING SOFTWARE COMPONENTS - A method for preventing regression defects when updating software components is disclosed. In one embodiment, such a method includes providing a source repository storing multiple software components (e.g., software modules, source files, sections of program code, etc.). The method determines associations between the software components and stores these associations in a database. The method further enables a user to check out a software component from the source repository in order to make updates, and check in the software component to the source repository once updates are made. At a designated time, such as when the software component is checked in or out, the method automatically checks the database to determine whether the software component has an association with any other software component in the source repository. The method notifies the user if an association is discovered. A corresponding computer program product and apparatus are also disclosed. | 01-24-2013 |
20130046100 | S-5-SUBSTITUENT-N-2'-(THIOPHENE-2-YL)ETHYL-TETRALIN-2-AMINE OR CHIRAL ACID SALTS THEREOF AND USE FOR PREPARING ROTIGOTINE - The chiral compound S-5-substituted-N-2′-(thienyl-2-yl-)ethyl-tetralin-2-amine or its chiral acid salts and preparation method thereof are disclosed, and the method for preparing Rotigotine by using the chiral compound is also disclosed. Racemic 5-substituted-N-2′-(thien-2-yl-)ethyl-tetralin-2-amine (compound 1) is resolved by using a conventional chiral acid to obtain an optically pure chiral acid salt of S-5-substituted-N-2′-(thien-2-yl-)ethyl-tetralin-2-amine, which is then dissociated to obtain S-5-substituted-N-2′-(thien-2-yl-)ethyl-tetralin-2-amine (compound 2). The compound 2 or chiral acid salt thereof is alkylated and deprotected to produce rotigotine (compound 5). | 02-21-2013 |
20130079521 | NOVEL PALONOSETRON SALTS AND PROCESSES FOR PREPARATION AND PURIFICATION THEREOF - Provided are novel salts of 2-(1-azabicyclo-[2.2.2]oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one, methods of using such salts, and processes for producing such salts. | 03-28-2013 |
20130089569 | RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS - The invention relates to recombinant MVA which is capable of expressing structural HCV antigens, functional parts of said structural antigens or epitopes of said structural antigens. The invention further relates to a pharmaceutical composition, especially in the form of a vaccine and containing the recombinant MVA according to the invention, to eukaryotic cells that contain the inventive recombinant MVA and to various uses of the recombinant MVA, for example for producing recombinant structural proteins, for producing a pharmaceutical preparation that is suitable for the therapy and prophylaxis of HCV infections and diseases thereby caused. The invention further relates to methods for producing recombinant MVA and recombinant structural HCV polypeptides encoded by said recombinant MVA, and to DNA or RNA of said recombinant MVA. | 04-11-2013 |
20130231488 | PROCESS FOR PREPARING 2-HYDROXYPHENYL ALKENYL BENZOTRIAZOLE COMPOUNDS; USE OF THE SAID COMPOUNDS OBTAINED VIA THE PROCESS IN THE SYNTHESIS OF SILOXANE COMPOUNDS CONTAINING A 2-HYDROXYPHENYLBENZOTRIAZOLE FUNCTION - The process for preparing 2-hydroxyphenyl alkenyl benzotriazole compounds and the process for preparing siloxane compounds containing 2-hydroxyphenyl benzotriazole function are disclosed. | 09-05-2013 |
20130331561 | Method of Preparation of Antiviral Compounds and Useful Intermediates Thereof - The invention is directed to processes for synthesizing bicyclic nucleoside antiviral compounds and for synthesizing the intermediates used in the process. The invention is also directed to novel intermediate compounds useful in the process. The anti-viral compounds are useful in the treatment of herpes zoster (i.e., varicella zoster virus, VZV, shingles) and for the prevention of post herpetic neuralgia (PHN) resulting from this viral infection. | 12-12-2013 |
20140250731 | Heel of a Shoe - Shoe heels with very thin titanium or aluminum alloy wires can achieve exotic visual effect, sophisticated variation in design and style, high strength, durable quality, lightweight and corrosion resistance. The heels comprise a first portion configured to join an outsole of the shoe, a second portion configured to support the shoe on the ground when the shoe is worn by a wearer, and a supporting structure joining the first portion to the second portion; wherein the supporting structure comprises one or more supporting wires; wherein at least one of the one or more supporting wires directly joins the first portion and at least one of the one or more supporting wires directly joins the second portion; wherein at least one of the one or more supporting wires comprises a material selected from a group consisting of titanium alloy, aluminum alloy, and a combination thereof. | 09-11-2014 |
20150078067 | METHOD OF MEASURING THRESHOLD VOLTAGE OF MOS TRANSISTOR IN SRAM ARRAY - Methods of measuring threshold voltages of MOS transistors in a SRAM array are provided. The SRAM array includes array-arranged cells having a first pass NMOS transistor, a second pass NMOS transistor, a first pull-down NMOS transistor, a second pull-down NMOS transistor, a first pull-up PMOS transistor, and a second pull-up transistor. A cell is selected from the SRAM array by a row decoding and a column decoding. A voltage is applied to a word line, a first bit line, a second bit line, a first power line, a second power line, a first substrate terminal, and/or a second substrate terminal, that are connected to the selected cell. A bit line current of the selected cell is measured to obtain a threshold voltage of a MOS transistor in the selected cell. Threshold voltages of a large number of MOS transistors in a SRAM array can be measured. | 03-19-2015 |